Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti-cancer agents in the adjuvant setting

Postoperative adjuvant chemotherapy for patients with stage III colon cancer (CC) is regarded as the standard treatment worldwide for outcome improvement and relapse prevention. Similarly, high-risk stage II CC requires adjuvant chemotherapy because of its high recurrence rate. Previous randomized c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: Mizuuchi, Yusuke, Tanabe, Yoshitaka, Sada, Masafumi, Kitaura, Yoshiki, Nagai, Shuntaro, Watanabe, Yusuke, Tamiya, Sadafumi, Nagayoshi, Kinuko, Ohuchida, Kenoki, Nakano, Toru, Nakamura, Masafumi
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2021
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082226/
https://ncbi.nlm.nih.gov/pubmed/33936595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2021.2284
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars